Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells

Cell Death and Differentiation

Volumn 11, Issue 4, 2004, Pages 448-457

  Kanzawa, T ^a,b   Germano, I M ^b   Komata, T ^b   Ito, H ^a,b   Kondo, Y ^a,b   Kondo, Sei ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Autophagy; LC3; Malignant glioma; Temozolomide

Indexed keywords

3 METHYLADENINE; ADENOSINE TRIPHOSPHATASE; ALKYLATING AGENT; BAFILOMYCIN A1; MICROTUBULE ASSOCIATED PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 3; TEMOZOLOMIDE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; AUTOPHAGY; CANCER CELL CULTURE; CELL CYCLE G2 PHASE; CELL ORGANELLE; CELL VACUOLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPLASM; DRUG CYTOTOXICITY; DRUG EFFECT; ENZYME ACTIVATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; LYSOSOME; LYSOSOME MEMBRANE; MEMBRANE PERMEABILITY; METAPHASE; MITOCHONDRIAL MEMBRANE; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

ADENINE; ANTINEOPLASTIC AGENTS, ALKYLATING; APOPTOSIS; AUTOPHAGY; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; DACARBAZINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLIOMA; HUMANS; MACROLIDES; MICROTUBULE-ASSOCIATED PROTEINS; ORGANELLES;

MAMMALIA; STAPHYLOCOCCUS PHAGE 3A;

EID: 1842865745     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401359     Document Type: Article

References (42)

1. Mahaley MS, Mettlin C, Matarajan N, Laws ER and Peace BB (1989) National survery of patterns of care for brain-tumor patients. J. Neurosurg. 71: 826-836
2. Avgeropoulos NG, and Batchelor TT (1994) New treatment strategies for malignant gliomas. Oncologist 4: 209-224
3. Bower M, Newlands ES, Bleehen NM, Brada M, Begent RJ, Calvert H, Colquhoun I, Lewis P and Brampton MH (1997) Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma. Cancer Chemother. Pharmacol. 40: 484-488
4. Yung WK, Prados MD, Yaya-Tur R, Rosenfeld SS, Brada M, Friedman HS, Albright R, Olson J, Chang SM, O'Neill AM, Friedman AH, Bruner J, Yue N, Dugan M, Zaknoen S and Levin VA (1999) Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic ligoastrocytoma at first relapse. Temodal Brain Tumor Group. J. Clin. Oncol. 17:2762-2771
5. Stevens MF, Hickman JA, Stone R, Gibson NW, Baig GU, Lunt E and Newton CG (1984) Antitumor imidazotetrazines. 1. Synthesis and chemistry of 8-carbamoyl-3-(2-chloroethyl)imidazo-1,2,3,5-tetrazin-4(3H)-one, a novel broad-spectrum antitumor agent. J. Med. Chem. 27: 196-201
6. Newlands ES, Stevens MF, Wedge SR, Wheelhouse RT and Brock C (1997) Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials. Cancer Treat. Rev. 23: 35-61
7. Agarwala SS and Kirkwood JM (2000) Temozolomide, a novel alkylating agent with activity in the central nervous system, may improve the treatment of advanced metastatic melanoma. Oncologist 5: 144-151
8. Friedman HS, Kerby T and Calvert H (2000) Temozolomide and treatment of malignant glioma. Clin. Cancer Res. 6: 2585-2597
9. Denny BJ, Wheelhouse RT, Stevens MF, Tsang LL and Slack JA (1994) NMR and molecular modeling investigation of the mechanism of activation of the antitumor drug temozolomide and its interaction with DNA. Biochemistry 33: 9045-9051
10. 6-alkylguanine-DNA alkyltransferase levels: studies with blasts of leukaemic patients. Ann. Oncol. 6: 389-393
11. D'Atri S, Tentori L, Lacal PM, Graziani G, Pagani E, Benincasa E, Zambruno G, Bonmassar E and Jiricny J (1998) Involvement of the mismatch repair system in temozolomide-induced apoptosis. Mol. Pharmacol. 54: 334-341
12. Hirose Y, Berger MS and Pieper RO (2001) p53 effects both the duration of G2/M arrest and the fate of temozolomide-treated human glioblastoma cells. Cancer Res. 61: 1957-1963
13. Kondo S, Barna BP, Morimura T, Takeuchi J, Yuan J, Akbasak A and Barnett GH (1995) Interleukin-1 β-converting enzyme mediates cisplatin-induced apoptosis in malignant glioma cells. Cancer Res. 55: 6166-6171
14. Bursch W, Ellinger A, Kienzl H, Torok L, Pandey S, Sikorska M, Walker R and Hermann RS (1996) Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy. Carcinogenesis 17: 1595-1607
15. Paglin S, Hollister T, Delohery T, Hackett N, McMahill M, Sphicas E, Domingo D and Yahalom J (2001) A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Res. 61: 439-444
16. Yao KC, Komata T, Kondo Y, Kanzawa T, Kondo S and Germano IM (2003) Molecular response of human glioblastoma multiforme cells to ionizing radiation: cell cycle arrest, modulation of the expression of cyclin-dependent kinase inhibitors, and autophagy. J. Neurosurg. 98: 378-384
17. Kanzawa T, Kondo Y, Ito H, Kondo S and Germano I (2003) Induction of autophagic cell death in malignant glioma cells by arsenic trioxide. Cancer Res. 63: 2103-2108
18. Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, Kominami E, Ohsumi Y and Yoshimori T (2000) LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 19: 5720-5728
19. Mizushima N, Yamamoto A, Hatano M, Kobayashi Y, Kabeya Y, Suzuki K, Tokuhisa T, Ohsumi Y and Yoshimori T (2001) Dissection of autophagosome formation using Apg5-deficient mouse embryonic stem cells. J. Cell Biol. 152: 657-668
20. Kim J and Klionsky DJ (2000) Autophagy, cytoplasm-to-vacuole targeting pathway, and pexophagy in yeast and mammalian cells. Annu. Rev. Biochem. 69: 303-342
21. Yamamoto A, Tagawa Y, Yoshimori T, Moriyama Y, Masaki R and Tashiro Y (1998) Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. Cell Struct. Funct. 23: 33-42
22. Manabe T, Yoshimori T, Henomatsu N and Tashiro Y (1993) Inhibitors of vacuolar-type H (+)-ATPase suppresses proliferation of cultured cells. J. Cell. Physiol. 157: 445-452
23. Munafo DB and Colombo MI (2001) A novel assay to study autophagy: regulation of autophagosome vacuole size by amino acid deprivation. J. Cell Sci. 114: 3619-3629
24. Nara A, Mizushima N, Yamamoto A, Kabeya Y, Ohsumi Y and Yoshimori T (2002) SKD1 AAA ATPase-dependent endosomal transport is involved in autolysosome formation. Cell Struct. Funct. 27: 29-37
25. Boya P, Gonzalez-Polo RA, Poncet D, Andreau K, Vieira HL, Roumier T, Perfettini JL and Kroemer G (2003) Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine. Oncogene 22: 3927-3936
26. Seglen PO and Bohley P (1992) Autophagy and other vacuolar protein degradation mechanisms. Experientia 48: 158-172
27. Blommaart EF, Krause U, Schellens JP, Vreeling-Sindelarova H and Meijer AJ (1997) The phosphatidylinositol 3-kinase inhibitors wortmannin and LY294002 inhibit autophagy in isolated rat hepatocytes. Eur. J. Biochem. 243: 240-246
28. Vanhaesebroeck B, Leevers SJ, Panayotou G and Waterfield MD (1997) Phosphoinositide 3-kinases: a conserved family of signal transducers. Trends Biochem. Sci. 22: 267-272
29. Toker A and Cantley LC (1997) Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature 387: 673-676
30. De Camilli P, Emr SD, McPherson PS and Novick P (1996) Phosphoinositides as regulators in membrane traffic. Science 271: 1533-1539
31. Petiot A, Ogier-Denis E, Blommaart EF, Meijer AJ and Codogno P (2000) Distinct classes of phosphatidylinositol 3′-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells. J. Biol. Chem. 275: 992-998
32. Klionsky DJ and Ohsumi Y (1999) Vacuolar import of proteins and organelles from the cytoplasm. Annu. Rev. Cell Dev. Biol. 15: 1-32
33. Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H and Levine B (1999) Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 402: 672-676
34. Arico S, Petiot A, Bauvy C, Dubbelhuis PF, Meijer A., Codogno P and Ogier-Denis E (2001) The tumor suppressor PTEN positively regulates macroautophagy by inhibiting the phosphatidylinositol 3-kinase/protein kinase B pathway. J. Biol. Chem. 276: 35243-35246
35. Ogier-Denis E and Codogno P (2003) Autophagy a barrier or an adaptive response to cancer. Biochim. Biophys. Acta 1603: 113-128
36. Altan N, Chen Y, Schindler M and Simon SM (1998) Defective acidification in human breast tumor cells and implications for chemotherapy. J. Exp. Med. 187: 1583-1598
37. Bursch W, Ellinger A, Gerner C, Frohwein U and Schulte-Hermann R (2000) Programmed cell death (PCD). Apoptosis, autophagic PCD, or others? Ann. NY Acad. Sci. 926: 1-12
38. Bursch W, Hochegger K, Torok L, Marian B, Ellinger A and Hermann RS (2000) Autophagic and apoptotic types of programmed cell death exhibit different fates of cytoskeletal filaments. J. Cell Sci. 113 (Part 7): 1189-1198
39. Komata T, Kondo Y, Koga S, Ko SC, Chung LW and Kondo S (2000) Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53. Gene Therapy 7: 2071-2079
40. Komata T, Kondo Y, Kanzawa T, Hirohata S, Koga S, Sumiyoshi H, Srinivasula SM, Barna BP, Germano IM, Takakura M, Inoue M, Alnemri ES, Shay JW, Kyo S and Kondo S (2001) Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptase) gene promoter. Cancer Res. 61: 5796-5802
41. Bruick RK (2000) Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc. Natl. Acad. Sci. USA 97: 9082-9087
42. Koga S, Hirohata S, Kondo Y, Komata T, Takakura M, Inoue M, Kyo S and Kondo S (2000A) Novel telomerase-specific gene therapy: gene transfer of caspase-8 utilizing the human telomerase catalytic subunit gene promoter. Hum. Gene Ther. 11: 1397-1406